Over a decade of successful treatment with tocilizumab in a maintenance hemodialysis patient for Castleman disease: a case report and literature review

Abstract Background Castleman disease (CD) is a rare, non-neoplastic lymphoproliferative disorder with characteristic histopathological features in lymph nodes. The clinical presentation of CD is highly variable, which can complicate both diagnosis and treatment. Tocilizumab, an interleukin-6 recept...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Aya Shima, Takahiro Shima, Chie Matsuo, Takaichi Suehiro, Tomohiko Kamimura, Hiroaki Niiro, Makoto Hirakawa
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2025-02-01
Edice:	Renal Replacement Therapy
Témata:	Castleman disease Maintenance hemodialysis Tocilizumab Long-term
On-line přístup:	https://doi.org/10.1186/s41100-025-00607-w
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!